Is the COVID-19 pandemic's end in sight?
Dr. Scott Gottlieb thinks so. The former commissioner of the Food and Drug Administration told CNBC on Friday he believes the coronavirus pandemic is nearing its end in the United States and could be "over" in two months. Gottlieb, a Pfizer board member, made the comments while reacting to Pfizer's announcement that its pill to treat COVID-19 is effective at reducing the risk of hospitalization and deaths.
"The bottom line is the end of the pandemic, at least as it relates to the United States, is in sight right now, given all the tools we have to combat this disease," Gottlieb said on CNBC.
The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Before this can happen, the United States will still need to get through the Delta wave of COVID-19 infections, Gottlieb said. But after that, he suggested therapeutics like Pfizer's pill coming to market will "mark the end of the pandemic for the United States," and as a result, "we need to think about how we put that victory sign on the sign of the White House, how we declare victory over this pandemic." He has previously suggested the Delta wave of COVID-19 cases would be the "last major wave of infection."
This comes after the Biden administration this week announced that Jan. 4 will be the deadline for large companies to adhere to his vaccine-or-testing mandate. "By Jan. 4, this pandemic may well be over, at least as it relates to the United States," at which point "we'll be in more of an endemic phase of this virus," Gottlieb predicted.
Others had similar reactions to the news from Pfzier on Friday, with Slow Boring writer Matthew Yglesias suggesting the drug company's results, combined with the approval of vaccines for children between 5 and 11, "makes it time for the White House/CDC to set a couple of clear benchmarks for declaring victory on COVID."
-
AI workslop is muddying the American workplaceThe explainer Using AI may create more work for others
-
Japan poised to get first woman prime ministerSpeed Read The ruling Liberal Democratic Party elected former Economic Security Minister Sanae Takaichi
-
The 5 best mob movies of all timeThe Week Recommends If you don’t like a good gangster flick, just fuhgeddaboudit
-
FDA OKs generic abortion pill, riling the rightSpeed Read The drug in question is a generic version of mifepristone, used to carry out two-thirds of US abortions
-
The new Stratus Covid strain – and why it’s on the riseThe Explainer ‘No evidence’ new variant is more dangerous or that vaccines won’t work against it, say UK health experts
-
RFK Jr. vaccine panel advises restricting MMRV shotSpeed Read The committee voted to restrict access to a childhood vaccine against chickenpox
-
Texas declares end to measles outbreakSpeed Read The vaccine-preventable disease is still spreading in neighboring states, Mexico and Canada
-
RFK Jr. shuts down mRNA vaccine funding at agencySpeed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year highSpeed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, changeSpeed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panelspeed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
